Basic streptococcal superantigens (SPEX/SMEZ or SPEC) are responsible for the mitogenic activity of the so-called

D Gerlach1, K H Schmidt, B Fleischer

  • 1Friedrich-Schiller-Universität Jena, Institute for Medical Microbiology, Semmelweisstr, 4, D-07743 Jena, Germany. i9gedi@rz.uni-jena.de

Insights

Group A Streptococcus mitogenic factor (MF) is not a superantigen but a DNase enzyme (streptodornase type B). MF

Area of Science:

  • Microbiology
  • Immunology
  • Enzymology

Background:

  • Group A Streptococcus mitogenic factor (MF) was previously identified as streptococcal pyrogenic exotoxin F (SPEF), a superantigen.
  • MF possesses both mitogenic and DNase activities.
  • Superantigens are known to stimulate T cells via specific Vbeta chains.

Purpose of the Study:

  • To purify and characterize the mitogenic factor (MF) from Streptococcus pyogenes.
  • To determine the precise nature of MF's superantigenic and DNase activities.
  • To clarify the classification of MF, specifically its relationship to superantigens and DNases.

Main Methods:

  • Purification of MF from culture supernatants of various Streptococcus pyogenes strains.
  • Assessment of Vbeta specificity of MF preparations.
  • Neutralization assays using antibodies against known streptococcal superantigens (SPEC, SPEX/SMEZ3) and MF.
  • Analysis of DNase activity of MF.
  • Molecular characterization of streptodornase type B (SDB) and comparison with MF.

Main Results:

  • MF preparations from different strains exhibited varying Vbeta specificities, linked to SPEC or SMEZ3 expression.
  • Mitogenic activity decreased with purification and was neutralized by anti-SPEC/SPEX antibodies, not anti-MF antibodies.
  • DNase activity of MF was completely neutralized by anti-MF antibodies.
  • MF was identified as streptodornase type B isoform II (SDBII), lacking superantigenic properties.
  • SDBII differs from SDBI by an additional N-terminal arginine.

Conclusions:

  • Mitogenic factor (MF) from Group A Streptococcus is identical to streptodornase type B isoform II (SDBII).
  • MF lacks superantigenic properties and should be reclassified, no longer termed a superantigen or pyrogenic exotoxin.
  • The study clarifies the dual activity of MF, attributing mitogenicity to superantigen contamination or interaction and the primary function to DNase activity.